Analystreport

Arcturus Therapeutics (ARCT) had its price target lowered by Piper Sandler from $72.00 to $25.00. They now have an "overweight" rating on the stock.

Arcturus Therapeutics Holdings Inc.  (ARCT) 
Last arcturus therapeutics holdings inc. earnings: 3/11 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.arcturusrx.com/investor-relations